{
  "label": "clinical_signal_03_ep_017",
  "artifact_type": "signal_episode",
  "artifact_id": "sha256:bd89cf127fe8ce28af2609c702fd06647b82347034cf0bfb835b2f19a4d19bd1",
  "input_ids": [
    "sha256:b4ba5337b06c8de68ac3315db1a4f6980c5bd48efd529c3914f30297d6afd329",
    "sha256:161174e8025b5c956602ccc4e17b4e677c58230b1b64641f357c400c448b8151"
  ],
  "prompt_id": null,
  "model_config": null,
  "created_at": "2026-02-17T11:55:06.295150",
  "content": "## 2024-06-24 Daily Operations Summary\n\n### Enrollment\n- Total Randomized: 225\n- Active: 214\n- Screen Failures Cumulative: 30\n- Withdrawals Cumulative: 11\n\n#### Sites\n- Site 01 Enrolled: 23\n- Site 01 Active: 23\n- Site 01 Statin Concomitant: 7\n- Site 02 Enrolled: 17\n- Site 02 Active: 17\n- Site 02 Statin Concomitant: 5\n- Site 03 Enrolled: 21\n- Site 03 Active: 21\n- Site 03 Statin Concomitant: 6\n- Site 04 Enrolled: 15\n- Site 04 Active: 15\n- Site 04 Statin Concomitant: 3\n- Site 05 Enrolled: 19\n- Site 05 Active: 19\n- Site 05 Statin Concomitant: 5\n- Site 06 Enrolled: 13\n- Site 06 Active: 13\n- Site 06 Statin Concomitant: 3\n- Site 07 Enrolled: 24\n- Site 07 Active: 24\n- Site 07 Statin Concomitant: 7\n- Site 08 Enrolled: 17\n- Site 08 Active: 17\n- Site 08 Statin Concomitant: 4\n- Site 09 Enrolled: 19\n- Site 09 Active: 19\n- Site 09 Statin Concomitant: 4\n- Site 10 Enrolled: 15\n- Site 10 Active: 15\n- Site 10 Statin Concomitant: 4\n- Site 11 Enrolled: 21\n- Site 11 Active: 21\n- Site 11 Statin Concomitant: 7\n- Site 12 Enrolled: 17\n- Site 12 Active: 17\n- Site 12 Statin Concomitant: 5\n\n### Lab Panels\n#### Statin Subgroup\n- N: 53\n- ALT (U/L) Mean: 89.1\n- ALT (U/L) Median: 86.5\n- AST (U/L) Mean: 65.7\n- AST (U/L) Median: 63.9\n- Bilirubin (mg/dL) Mean: 1.13\n- Bilirubin (mg/dL) Median: 1.1\n- ALP (U/L) Mean: 80.0\n- ALP (U/L) Median: 75.0\n- Creatinine (mg/dL) Mean: 0.88\n- Creatinine (mg/dL) Median: 0.86\n- BUN (mg/dL) Mean: 16.0\n- BUN (mg/dL) Median: 16.5\n- WBC (K) Mean: 7.9\n- WBC (K) Median: 6.9\n- Platelets (K) Mean: 249\n- Platelets (K) Median: 243\n\n#### Non-Statin Subgroup\n- N: 130\n- ALT (U/L) Mean: 29.6\n- ALT (U/L) Median: 29.5\n- AST (U/L) Mean: 21.7\n- AST (U/L) Median: 20.8\n- Bilirubin (mg/dL) Mean: 0.46\n- Bilirubin (mg/dL) Median: 0.42\n- ALP (U/L) Mean: 68.4\n- ALP (U/L) Median: 62.2\n- Creatinine (mg/dL) Mean: 0.9\n- Creatinine (mg/dL) Median: 0.89\n- BUN (mg/dL) Mean: 15.7\n- BUN (mg/dL) Median: 15.3\n- WBC (K) Mean: 8.0\n- WBC (K) Median: 5.7\n- Platelets (K) Mean: 252\n- Platelets (K) Median: 230\n\n### Adverse Events\n- AE ID: AE-0059, Description: back pain, Grade: 1, Relatedness: not related, Resolved: true, Subject Group: statin\n- AE ID: AE-0060, Description: insomnia, Grade: 1, Relatedness: unlikely related, Resolved: true, Subject Group: non_statin\n- AE ID: AE-0061, Description: hepatic enzyme measurement out of range, Grade: 2, Relatedness: probably related, Resolved: true, Subject Group: statin\n- AE ID: AE-0062, Description: nausea, Grade: 2, Relatedness: probably related, Resolved: true, Subject Group: statin\n- AE ID: AE-0063, Description: abdominal pain, Grade: 2, Relatedness: possibly related, Resolved: true, Subject Group: statin\n\n### Concomitant Meds\n- Statin Count: 54\n- ACE Inhibitor Count: 26\n- Metformin Count: 22\n- PPI Count: 18\n- NSAID Count: 13\n- Other Count: 34\n\n### Protocol Deviations\n- PD ID: PD-035, Description: Informed consent version outdated by 1 revision, Severity: minor, Site: site_10\n- PD ID: PD-036, Description: Eligibility criterion reassessed, subject confirmed eligible, Severity: minor, Site: site_04\n\n### Investigator Notes\n- Lab kits inventory adequate for next 4 weeks\n- Enrollment on track per protocol timeline\n- Site pharmacy inventory verified\n\n### Events\n- Medical monitor weekly call completed\n- Central lab courier pickup schedule adjusted for holiday\n\n### Notes\n- Week 17: Statin subgroup hepatic enzymes 2-3x ULN across sites. SAE reports under review. Non-statin subgroup within range.",
  "metadata": {
    "episode_id": "clinical_signal_03_ep_017",
    "scope_id": "clinical_signal_03",
    "timestamp": "2024-06-24T10:00:00",
    "phase": "escalation",
    "signal_density": "high",
    "episode_type": "signal",
    "layer_name": "signal_episodes",
    "layer_level": 2,
    "build_fingerprint": {
      "scheme": "synix:build:v1",
      "digest": "724335e48952198659b608a79f591f6985cc457d1b0726c271a193e4d218a284",
      "components": {
        "transform": "f5403588af46952374060f29447e5a7639e5b66fc9aef1799b08473882c4bcbc",
        "inputs": "a94b84fbaca9bd62"
      }
    },
    "transform_fingerprint": {
      "scheme": "synix:transform:v2",
      "digest": "f5403588af46952374060f29447e5a7639e5b66fc9aef1799b08473882c4bcbc",
      "components": {
        "transform_id": "cb4ddfa83a38701b",
        "source": "42e76241d396a578",
        "model": "1e2ccf75e96d7ee7"
      }
    }
  }
}